Surrozen
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
171 Oyster Point Blvd Ste 400, South San...Phone Number
(650) 475-2820Website
www.surrozen.comRevenue
$7.5 MillionStock Symbol
SRZNIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Surrozen
Surrozen is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. Surrozen is developing tissue-specific antibodies designed to engage the body's existing biological repair mechanisms with potential application across multiple disease areas, including inflammatory bowel disease, hepatitis, eye diseases, hearing loss, lung and airway diseases, and certain neurological disorders.Explore more
Surrozen Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Surrozen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Surrozen launches new products
Funding: Get notified immidiatlly once Surrozen has new funding data
Congratulate Masked Content for being promoted to Masked Content at Surrozen
Check out if Surrozen is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Surrozen recently announced quarterly report
Click to see if Surrozen had a recent Job posting/layoffs
Check if Surrozen has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Surrozen, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Surrozen as Masked Content
Find 2 more new buyers
Compare Similar Companies to Surrozen
Compare insights from companies similar to Surrozen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$6.5M
11-50
Public
$340.5M
2015
KB
Kristi BalacyHead Senior Director, Clinical Development Operations & of Clinical Operations
Company Profile Activity
Activity Insights
Surrozen is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Surrozen is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Surrozen.
Surrozen financials insights
Gather financial insights about Surrozen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$33M
2019
Series B
$50M
2020
Series C
$50M
2025
Share Placement
$175M
Surrozen Tech Stack
A closer look at the technologies used by Surrozen
See more technologies
Most Recent Scoops
Person-Based
Product Development, Medical Research, Pharmaceuticals
Project
Surrozen has reported that its SZN-8141 molecule, which binds Fzd4 and LRP5 to activate WNT signaling, is a direct competitor to Merck's Restoret molecule. Surrozen believes SZN-8141 is a more potent WNT activator than Restoret.
Medical Research, Pharmaceuticals
Project
Surrozen has reported that its combination approach can eliminate leakage from damaged vessels and reperfuse areas of the retina at very low doses, addressing areas that would otherwise appear as black spots under microscopic examination.
Medical Research
Project
Surrozen has reported that its SZN-8143 molecule is behind SZN-8141 in development, with the initial strategy targeting more inflammatory-driven diseases such as uveitic macular edema.
Product Development, Pharmaceuticals
Project
Research & Development, Pharmaceuticals
Surrozen News & Media
Surrozen Reports First Quarter 2026 Financial Results and Provides Business Update
Surrozen Reports First Quarter 2026 Financial Results and Provides Business UpdateSurrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Surrozen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Surrozen Reports Fourth Quarter and Full Year 2025 Financial Results and Business UpdateSurrozen to Present at Upcoming Healthcare Investor Conference
Surrozen to Present at Upcoming Healthcare Investor Conference
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Surrozen
Sign Up For FreeTo access detailed company insights
Surrozen is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. Surrozen is developing tissue-specific antibodies designed to engage the body's existing biological repair mechanisms with potential application across multiple disease areas, including inflammatory bowel disease, hepatitis, eye d... Read More
